Anna Scomparin
Impact in
- Biomaterials top 2%
- Nanoparticle-Based Drug Delivery
- Pharmaceutical Science top 2%
- Advanced Drug Delivery Systems
Papers in
-
- RNA Interference and Gene Delivery 19
- Advanced biosensing and bioanalysis techniques 16
-
- Nanoplatforms for cancer theranostics 10
- Graphene and Nanomaterials Applications 4
- Co-authors
- Ronit Satchi‐Fainaro (33 shared papers)Anat Eldar‐Boock (7 shared papers)Galia Tiram (9 shared papers)Dina Polyak (8 shared papers)Paula Ofek (6 shared papers)Doron Shabat (5 shared papers)Adva Krivitsky (10 shared papers)Paolo Caliceti (9 shared papers)
- Journals
- Journal of Controlled Release (7 papers)Bioconjugate Chemistry (4 papers)Pharmaceutics (2 papers)Advanced Drug Delivery Reviews (2 papers)Drug Delivery and Translational Research (2 papers)
- Partner nations
- IsraelItalyUnited States
In The Last Decade
Anna Scomparin
47 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 114
- Biomaterials 578
- Pharmaceutical Science 156
- Immunology 297
- Biomedical Engineering 586
- Molecular Medicine 62
Countries citing papers authored by Anna Scomparin
This map shows the geographic impact of Anna Scomparin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Scomparin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Scomparin more than expected).
Fields of papers citing papers by Anna Scomparin
This network shows the impact of papers produced by Anna Scomparin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Scomparin. The network helps show where Anna Scomparin may publish in the future.
Co-authors
The 25 scholars most cited alongside Anna Scomparin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 47 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 245 | |
| 2 | 2019 | 190 | |
| 3 | 2013 | 95 | |
| 4 | 2018 | 92 | |
| 5 | 2016 | 89 | |
| 6 | 2017 | 81 | |
| 7 | 2017 | 75 | |
| 8 | 2019 | 72 | |
| 9 | 2019 | 64 | |
| 10 | 2015 | 63 | |
| 11 | 2011 | 62 | |
| 12 | 2013 | 53 | |
| 13 | 2019 | 53 | |
| 14 | 2021 | 49 | |
| 15 | 2020 | 44 | |
| 16 | 2019 | 41 | |
| 17 | 2015 | 39 | |
| 18 | 2013 | 36 | |
| 19 | 2015 | 35 | |
| 20 | 2023 | 31 |
About Anna Scomparin
Anna Scomparin is a scholar working on Molecular Biology, Biomedical Engineering, Oncology, Biomaterials and Immunology, having authored 47 papers that have together received 1.9k indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (19 papers), Advanced biosensing and bioanalysis techniques (16 papers), Nanoparticle-Based Drug Delivery (11 papers), Nanoplatforms for cancer theranostics (10 papers), Immunotherapy and Immune Responses (8 papers), Advanced Drug Delivery Systems (5 papers), Graphene and Nanomaterials Applications (4 papers) and Click Chemistry and Applications (3 papers). The work is most often cited by research in Biomaterials (578 citations), Pharmaceutical Science (156 citations), Immunology (297 citations), Biomedical Engineering (586 citations) and Molecular Medicine (62 citations). Anna Scomparin has collaborated with scholars based in Israel, Italy and United States. Frequent co-authors include Ronit Satchi‐Fainaro, Anat Eldar‐Boock, Galia Tiram, Dina Polyak, Paula Ofek, Doron Shabat, Adva Krivitsky, Paolo Caliceti, Stefano Salmaso and Shiran Ferber. Their work appears in journals such as Journal of Controlled Release, Bioconjugate Chemistry, Pharmaceutics, Advanced Drug Delivery Reviews and Drug Delivery and Translational Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.